Four California counties are demanding $50 billion from Johnson & Johnson, Teva Pharmaceutical Industries, Endo International Plc, and Allergan Plc for their roles in marketing and distributing powerful opioid narcotics throughout their communities. And, as thousands of other municipalities and localities wait to have their own days in court to hold pharmaceutical manufacturers responsible, both sides are paying very close attention to what happens in the California ...
All Eyes on California as $50 Billion Opioid Trial Sets Stage for What’s to Come
Posted June 9, 2021 in Drug and Medical Device Lawsuits | Product News and Recalls
First Testim Trial Ends with Decision in Favor of Drugmaker
Posted December 5, 2017 in Drug and Medical Device Lawsuits | Product News and Recalls | Testosterone Therapy
Testim maker Endo International’s Auxilium unit emerged victorious in the first trial over whether its testosterone therapy drug caused a heart attack in a patient.
The Tennessee plaintiff had been prescribed Testim for what he described as chronic fatigue and had been applying the testosterone gel to himself for over 6 months. In July 2014, he suffered a heart attack and was subsequently hospitalized twice. His recovery since ...
continue reading...Opana ER Pulled from Shelves Over Abuse Concerns
Posted September 12, 2017 in Drug and Medical Device Lawsuits | Product News and Recalls
Endo Pharmaceuticals has officially withdrawn Opana ER from the market at the FDA’s request. The extended release opioid medication recently became the subject of an inquiry by the agency because of the specific way it was being abused.
Opana ER was designed to slowly and steadily medicate a patient as an extended release medication. However, when crushed, snorted, or injected, an abuser can get the full dose ...
continue reading...
